BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 17350572)

  • 1. Structural and biochemical studies of ALIX/AIP1 and its role in retrovirus budding.
    Fisher RD; Chung HY; Zhai Q; Robinson H; Sundquist WI; Hill CP
    Cell; 2007 Mar; 128(5):841-52. PubMed ID: 17350572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ALIX-CHMP4 interactions in the human ESCRT pathway.
    McCullough J; Fisher RD; Whitby FG; Sundquist WI; Hill CP
    Proc Natl Acad Sci U S A; 2008 Jun; 105(22):7687-91. PubMed ID: 18511562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and functional studies of ALIX interactions with YPX(n)L late domains of HIV-1 and EIAV.
    Zhai Q; Fisher RD; Chung HY; Myszka DG; Sundquist WI; Hill CP
    Nat Struct Mol Biol; 2008 Jan; 15(1):43-9. PubMed ID: 18066081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of the Bro1 domain protein BROX and functional analyses of the ALIX Bro1 domain in HIV-1 budding.
    Zhai Q; Landesman MB; Robinson H; Sundquist WI; Hill CP
    PLoS One; 2011; 6(12):e27466. PubMed ID: 22162750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for viral late-domain binding to Alix.
    Lee S; Joshi A; Nagashima K; Freed EO; Hurley JH
    Nat Struct Mol Biol; 2007 Mar; 14(3):194-9. PubMed ID: 17277784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent rescue of human immunodeficiency virus type 1 late domain mutants by ALIX/AIP1 depends on its CHMP4 binding site.
    Usami Y; Popov S; Göttlinger HG
    J Virol; 2007 Jun; 81(12):6614-22. PubMed ID: 17428861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alix-Mediated Rescue of Feline Immunodeficiency Virus Budding Differs from That Observed with Human Immunodeficiency Virus.
    Del Vecchio C; Celestino M; Celegato M; Palù G; Parolin C; Bouamr F; Calistri A
    J Virol; 2020 May; 94(11):. PubMed ID: 32213612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding.
    Strack B; Calistri A; Craig S; Popova E; Göttlinger HG
    Cell; 2003 Sep; 114(6):689-99. PubMed ID: 14505569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decoding the intrinsic mechanism that prohibits ALIX interaction with ESCRT and viral proteins.
    Zhou X; Si J; Corvera J; Gallick GE; Kuang J
    Biochem J; 2010 Dec; 432(3):525-34. PubMed ID: 20929444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A crescent-shaped ALIX dimer targets ESCRT-III CHMP4 filaments.
    Pires R; Hartlieb B; Signor L; Schoehn G; Lata S; Roessle M; Moriscot C; Popov S; Hinz A; Jamin M; Boyer V; Sadoul R; Forest E; Svergun DI; Göttlinger HG; Weissenhorn W
    Structure; 2009 Jun; 17(6):843-56. PubMed ID: 19523902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Divergent Bro1 domains share the capacity to bind human immunodeficiency virus type 1 nucleocapsid and to enhance virus-like particle production.
    Popov S; Popova E; Inoue M; Göttlinger HG
    J Virol; 2009 Jul; 83(14):7185-93. PubMed ID: 19403673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and structural characterization of the ALIX-binding late domains of simian immunodeficiency virus SIVmac239 and SIVagmTan-1.
    Zhai Q; Landesman MB; Robinson H; Sundquist WI; Hill CP
    J Virol; 2011 Jan; 85(1):632-7. PubMed ID: 20962096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The HIV-1 p6/EIAV p9 docking site in Alix is autoinhibited as revealed by a conformation-sensitive anti-Alix monoclonal antibody.
    Zhou X; Pan S; Sun L; Corvera J; Lin SH; Kuang J
    Biochem J; 2008 Sep; 414(2):215-20. PubMed ID: 18476810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The YLDL sequence within Sendai virus M protein is critical for budding of virus-like particles and interacts with Alix/AIP1 independently of C protein.
    Irie T; Shimazu Y; Yoshida T; Sakaguchi T
    J Virol; 2007 Mar; 81(5):2263-73. PubMed ID: 17166905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The nucleocapsid region of HIV-1 Gag cooperates with the PTAP and LYPXnL late domains to recruit the cellular machinery necessary for viral budding.
    Dussupt V; Javid MP; Abou-Jaoudé G; Jadwin JA; de La Cruz J; Nagashima K; Bouamr F
    PLoS Pathog; 2009 Mar; 5(3):e1000339. PubMed ID: 19282983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Insight into the Interaction of Sendai Virus C Protein with Alix To Stimulate Viral Budding.
    Oda K; Matoba Y; Sugiyama M; Sakaguchi T
    J Virol; 2021 Sep; 95(19):e0081521. PubMed ID: 34287046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus type 1 Gag engages the Bro1 domain of ALIX/AIP1 through the nucleocapsid.
    Popov S; Popova E; Inoue M; Göttlinger HG
    J Virol; 2008 Feb; 82(3):1389-98. PubMed ID: 18032513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solution structure of the equine infectious anemia virus p9 protein: a rationalization of its different ALIX binding requirements compared to the analogous HIV-p6 protein.
    Sharma A; Bruns K; Röder R; Henklein P; Votteler J; Wray V; Schubert U
    BMC Struct Biol; 2009 Dec; 9():74. PubMed ID: 20015412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Budding of retroviruses utilizing divergent L domains requires nucleocapsid.
    Bello NF; Dussupt V; Sette P; Rudd V; Nagashima K; Bibollet-Ruche F; Chen C; Montelaro RC; Hahn BH; Bouamr F
    J Virol; 2012 Apr; 86(8):4182-93. PubMed ID: 22345468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human ESCRT and ALIX proteins interact with proteins of the midbody and function in cytokinesis.
    Morita E; Sandrin V; Chung HY; Morham SG; Gygi SP; Rodesch CK; Sundquist WI
    EMBO J; 2007 Oct; 26(19):4215-27. PubMed ID: 17853893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.